It should have stopped a long time ago. Im assuming you are referring to the resale registration. Almost all of those warrants were at 0.75 before the registration anyway. In my opinion, cleaning up those warrants vs issuing new shares is a VERY GOOD thing. As far as future dilution goes, thats a never-ending story for ALL pre revenue companies. And what we are seeing right now is absolutely NOT the product of dilution. This last offering should have set us down right around 0.90. In my opinion thats why we saw such huge volume buying into the low 0.80's. But the one thing no one is really talking about right now is what price SHOULD we be at. Right now we're not anywhere close to the ballpark! This selling or shorting has gotten so out of control we aren't even in the same state as the ballpark anymore. I know, I know, "Who can put an accurate valuation on a pre FDA approval stock?" But we CAN! Analysts have been doing this since the beginning of time! Future cash flows, probability of success, time discounts, etc, etc, is all calculated to tell you the present value of the stock your looking at. This is no secret. Anyone that wants to get into the numbers can read through the DCF analysis in each analyst report. Anyway, yeah the selling should stop, should have stopped. I dont have an answer. Im just sticking to my original investment thesis.